Lupron v. orgovyx...which is preferable for the heart?

Posted by bigdaddyalso @bigdaddyalso, Oct 24 9:59pm

have A/FIB and CHF, drugs: xarelto amd metropolol. metastatic Prostate cancer in lungs and some lymph glands, caught early. began LUPRON/NUBEQA in april. effective. since july, Testosterone = 13 and PSA < 0.01, ie: undetectable. side effects, i handle it.
what me and the docs are looking for is info, any advantage of Orgovyx v. Lupron. any reason to switch . any advantage for heart function.? diminuation of risk?

Interested in more discussions like this? Go to the Prostate Cancer Support Group.

FWIW...I am a CHF patient as well. I was put on Orgovyx/Nubeqa with concurrence from my Cardio-Oncologist after consult with my Genito-Urinary Oncologist.

From the below linked article, "Recent data reinforces that GnRH antagonists have a more favorable cardiovascular outcomes compared to GnRH agonists yet maintain a similar efficacy profile."

The studies referenced in the article, and the article itself, along with an echo EF of 30-35%, were used for pre-auth to get my insurance company to cover it.
https://pmc.ncbi.nlm.nih.gov/articles/PMC8254069/
Best wishes!

REPLY

GnRH: Gonadotropin Releasing Hormone
Antagonists of GnRH:
LUPRON [ELIGARD], (leuprolide)
ORGOVYX, (relugolix)

An advantage of ORGOVYX may be that its effects are daily and withdrawal has immediate results but heart effects may relate to its cumulative effect to the point when stopped. [Lay opinion]

REPLY
Profile picture for thmssllvn @thmssllvn

GnRH: Gonadotropin Releasing Hormone
Antagonists of GnRH:
LUPRON [ELIGARD], (leuprolide)
ORGOVYX, (relugolix)

An advantage of ORGOVYX may be that its effects are daily and withdrawal has immediate results but heart effects may relate to its cumulative effect to the point when stopped. [Lay opinion]

Jump to this post

@thmssllvn Correction: Lupron is a GnRH agonist. Orgovyx is a GnRH antagonist. Different mechanisms of action.

REPLY

While the following information discusses the comparison even if the person taking Lupron has Casodex for a couple of weeks before a lupron injection.

When it comes to heart-related side effects, Orgovyx (relugolix), a GnRH antagonist, has consistently been shown to have a more favorable cardiovascular profile than Lupron (leuprolide), a GnRH agonist, even when a "flare-reducing" drug like Casodex is used before starting Lupron. The key difference lies in their mechanism of action and the resulting effects on testosterone levels.

REPLY

The only thing I know of is one’s a pill form and Lupron is an injection

REPLY
Profile picture for mjp0512 @mjp0512

FWIW...I am a CHF patient as well. I was put on Orgovyx/Nubeqa with concurrence from my Cardio-Oncologist after consult with my Genito-Urinary Oncologist.

From the below linked article, "Recent data reinforces that GnRH antagonists have a more favorable cardiovascular outcomes compared to GnRH agonists yet maintain a similar efficacy profile."

The studies referenced in the article, and the article itself, along with an echo EF of 30-35%, were used for pre-auth to get my insurance company to cover it.
https://pmc.ncbi.nlm.nih.gov/articles/PMC8254069/
Best wishes!

Jump to this post

@mjp0512 thank you

REPLY
Profile picture for mjp0512 @mjp0512

@thmssllvn Correction: Lupron is a GnRH agonist. Orgovyx is a GnRH antagonist. Different mechanisms of action.

Jump to this post

from biddaddyalso.......after reading the meta study y'all named i decided to do the switch, as the ONC suggested, pending ok from cardio. info lacking in summary IE: who are subjects incomplete so unsure if my CHF is included and and etc?. but writer clear about the relative disadvantages of agonists (LUPRON)over time. i did not read yet any of the studies referenced. also, there is a risk with orgovyx related to "long QT syndrome"
a restraint to orgovyx is cost. 2k monthly. with medicare DR. Google say $100 mthy. add the NUBEQA , well do the math. this year. max out of pocket drog is $2,100, of this i am certain. otherwise i couldnot afford.

REPLY
Profile picture for bigdaddyalso @bigdaddyalso

from biddaddyalso.......after reading the meta study y'all named i decided to do the switch, as the ONC suggested, pending ok from cardio. info lacking in summary IE: who are subjects incomplete so unsure if my CHF is included and and etc?. but writer clear about the relative disadvantages of agonists (LUPRON)over time. i did not read yet any of the studies referenced. also, there is a risk with orgovyx related to "long QT syndrome"
a restraint to orgovyx is cost. 2k monthly. with medicare DR. Google say $100 mthy. add the NUBEQA , well do the math. this year. max out of pocket drog is $2,100, of this i am certain. otherwise i couldnot afford.

Jump to this post

@bigdaddyalso
I have afib which is particularly susceptible to long QT syndrome. I have a couple events specifically caused by it when I was on Zytiga and Lupron.

I have never had a problem since I’ve been on Orgovyx and Nubeqa.

Just another point of view.

REPLY
Please sign in or register to post a reply.